RT Journal Article
SR Electronic
T1 The relationship between BMI and COVID-19: exploring misclassification and selection bias in a two-sample Mendelian randomisation study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.03.22271836
DO 10.1101/2022.03.03.22271836
A1 Clayton, Gemma L
A1 Gonçalves Soares, Ana
A1 Goulding, Neil
A1 Borges, Maria Carolina
A1 Holmes, Michael V
A1 Davey Smith, George
A1 Tilling, Kate
A1 Lawlor, Deborah A
A1 Carter, Alice R
YR 2022
UL http://medrxiv.org/content/early/2022/03/05/2022.03.03.22271836.abstract
AB Objective To use the example of the effect of body mass index (BMI) on COVID-19 susceptibility and severity to illustrate methods to explore potential selection and misclassification bias in Mendelian randomisation (MR) of COVID-19 determinants.Design Two-sample MR analysis.Setting Summary statistics from the Genetic Investigation of ANthropometric Traits (GIANT) and COVID-19 Host Genetics Initiative (HGI) consortia.Participants 681,275 participants in GIANT and more than 2.5 million people from the COVID-19 HGI consortia.Exposure Genetically instrumented BMI.Main outcome measures Seven case/control definitions for SARS-CoV-2 infection and COVID-19 severity: very severe respiratory confirmed COVID-19 vs not hospitalised COVID-19 (A1) and vs population (those who were never tested, tested negative or had unknown testing status (A2)); hospitalised COVID-19 vs not hospitalised COVID-19 (B1) and vs population (B2); COVID-19 vs lab/self-reported negative (C1) and vs population (C2); and predicted COVID-19 from self-reported symptoms vs predicted or self-reported non-COVID-19 (D1).Results With the exception of A1 comparison, genetically higher BMI was associated with higher odds of COVID-19 in all comparison groups, with odds ratios (OR) ranging from 1.11 (95%CI: 0.94, 1.32) for D1 to 1.57 (95%CI: 1.57 (1.39, 1.78) for A2. As a method to assess selection bias, we found no strong evidence of an effect of COVID-19 on BMI in a ‘no-relevance’ analysis, in which COVID-19 was considered the exposure, although measured after BMI. We found evidence of genetic correlation between COVID-19 outcomes and potential predictors of selection determined a priori (smoking, education, and income), which could either indicate selection bias or a causal pathway to infection. Results from multivariable MR adjusting for these predictors of selection yielded similar results to the main analysis, suggesting the latter.Conclusions We have proposed a set of analyses for exploring potential selection and misclassification bias in MR studies of risk factors for SARS-CoV-2 infection and COVID-19 and demonstrated this with an illustrative example. Although selection by socioeconomic position and arelated traits is present, MR results are not substantially affected by selection/misclassification bias in our example. We recommend the methods we demonstrate, and provide detailed analytic code for their use, are used in MR studies assessing risk factors for COVID-19, and other MR studies where such biases are likely in the available data.What is already known on this topic- Mendelian randomisation (MR) studies have been conducted to investigate the potential causal relationship between body mass index (BMI) and COVID-19 susceptibility and severity.- There are several sources of selection (e.g. when only subgroups with specific characteristics are tested or respond to study questionnaires) and misclassification (e.g. those not tested are assumed not to have COVID-19) that could bias MR studies of risk factors for COVID-19.- Previous MR studies have not explored how selection and misclassification bias in the underlying genome-wide association studies could bias MR results.What this study adds- Using the most recent release of the COVID-19 Host Genetics Initiative data (with data up to June 2021), we demonstrate a potential causal effect of BMI on susceptibility to detected SARS-CoV-2 infection and on severe COVID-19 disease, and that these results are unlikely to be substantially biased due to selection and misclassification.- This conclusion is based on no evidence of an effect of COVID-19 on BMI (a ‘no-relevance control’ study, as BMI was measured before the COVID-19 pandemic) and finding genetic correlation between predictors of selection (e.g. socioeconomic position) and COVID-19 for which multivariable MR supported a role in causing susceptibility to infection.- We recommend studies use the set of analyses demonstrated here in future MR studies of COVID-19 risk factors, or other examples where selection bias is likely.Competing Interest StatementKT report funding from UK Medical Research Council, for work unrelated to that presented here. DAL reports receiving support from several national and international government and charity research funders, and grants from Medtronic Ltd for work unrelated to that presented here. GLC, AGS, ARC, NG declare that they have no competing interests.Funding StatementThis work was supported by the Bristol British Heart Foundation (BHF) Accelerator Award (AA/18/7/34219, which supports ARC); the University of Bristol and Medical Research Council (MRC) Integrative Epidemiology Unit (MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/6, which supports ARC, GLC, AGS, NG, GDS, DAL, KT, and MCB); the BHF-National Institute of Health Research (NIHR) COVIDITY flagship project; the European Union's Horizon 2020 research and innovation programme (under grant agreement No 733206 LifeCycle, which supports GLC and DAL); the Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases (H2020-SC1-2019-Single-Stage-RTD, project ID 874739, which supports AGS); the University of Bristol (Vice-Chancellor's Fellowships, which supports MCB); the British Heart foundation (CH/F/20/90003, to DAL); and the NIHR (NF-0616-10102, to DAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the purpose of Open Access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This publication is the work of the authors and Gemma L Clayton, Ana Goncalves Soares, Neil Goulding, Deborah Lawlor and Alice R Carter will serve as guarantors for the contents of this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The datasets analysed during the current study are all publicly available GWAS (i.e. https://www.covid19hg.org/). Ethics approval was not required for this study, given only summary-level (GWAS) data has been used.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analysed during the current study are all publicly available GWAS. Analysis scripts and the analysis plan can be found on the following GitHub page: https://github.com/gc13313/BMI_COVID_2SMR.